Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Exciting trial updates from the upcoming SABCS 2020 meeting

Cynthia X. Ma, MD, PhD, Washington University School of Medicine in St. Louis, St. Louis, MO, discussing upcoming studies to be presented at the San Antonio Breast Cancer Symposium (SABCS) including updates in the monarchE study evaluating standard adjuvant endocrine therapy with or without abemaciclib in patients with high risk, node positive, hormone-receptor positive, human epidermal growth factor receptor 2-negative early-stage breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).


Dr. Ma reports funding from Pfizer, Puma.

Dr. Ma reports consulting and advisory for Novartis, Bayer, Eisai, Athenex, OncoSignal, Seattle Genetics, Eli Lilly.